Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration

被引:15
|
作者
Javadikasgari, Hoda [1 ]
Chemtob, Raphaelle A. [1 ]
Gillinov, A. Marc [1 ]
Pettersson, Gosta B. [1 ]
Lowry, Ashley M. [3 ]
Desai, Milind Y. [2 ]
Svensson, Lars G. [1 ]
Blackstone, Eugene H. [1 ,3 ]
Wierup, Per [1 ]
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc & Thorac Inst, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Heart Vasc & Thorac Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA
关键词
heart valve replacement; outcomes research; causes of death; survival; RISK-FACTORS; SURGERY; IMPLANTATION; SOCIETY; GUIDELINES; EXPERIENCE; GRADIENT;
D O I
10.1016/j.jtcvs.2020.08.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Reoperation for structural valve deterioration (SVD) of bioprosthetic mitral valves carries a presumed high operative risk, and transcatheter mitral valve-in-valve implantation has emerged as an alternative. However, surgical risk and long-term outcome following mitral valve re-replacement in these patients remain ill-defined. Hence, we sought to evaluate outcomes and long-term survival following surgical mitral valve re-replacement and to identify risk factors for mortality. Methods: From January 1990 to January 2017, 525 patients underwent surgical mitral valve re-replacement at Cleveland Clinic for bioprosthetic SVD: 133 (25%) isolated operations and 392 (75%) with concomitant procedures. Surgical complications and modes of death were compiled, long-term mortality assessed, and risk factors identified using a multivariable nonproportional hazards model and random forest analysis. Results: SVD was characterized by bioprosthetic regurgitation in 81% (425 out of 525) and stenosis in 44%(231 out of 525). One in-hospital death occurred after isolated valve re-replacement (0.75%) and 28 deaths occurred (7.1%; P =.003) after nonisolated re-replacement, 19 (68%) of which were from coagulopathy, vasoplegia, and multisystem organ failure. In the nonisolated group, incremental risk factors for time-related death after re-replacement included New York Heart Association functional class IV symptoms, concomitant coronary artery bypass grafting, prolonged cardiopulmonary bypass time, and transfusions. Conclusions: Mitral valve re-replacement for bioprosthetic SVD was associated with low surgical risk and excellent long-term survival. Isolated mitral valve re-replacement for bioprosthetic SVD had near-zero surgical risk. Excessive cardiopulmonary bypass duration and multiple transfusions correlated with increased early mortality in nonisolated procedures, as did preoperative severe heart failure. Optimal surgical plan and timing of surgery are keys to success.
引用
收藏
页码:1804 / +
页数:14
相关论文
共 50 条
  • [21] Developing Hemodynamic Valve Deterioration and Mortality in Aortic Valve Replacement
    Kim, Hee Jung
    Yang, Kyung-Sook
    Kim, Joon Bum
    Jung, Sung-Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Lee, Jae Won
    JOURNAL OF SURGICAL RESEARCH, 2023, 285 : 236 - 242
  • [22] Structural deterioration of the cryopreserved mitral homograft valve
    Olivito, Silvio
    Lalande, Stephanie
    Nappi, Francesco
    Hammoudi, Nadjib
    D'Alessandro, Cosimo
    Fouret, Pierre
    Acar, Christophe
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (02) : 313 - +
  • [23] Reoperative "valve-in-valve" transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic valve replacement and a degenerated bioprosthetic mitral valve
    de Biasi, Andreas R.
    Wong, Shing-Chiu
    Salemi, Arash
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05) : E209 - E210
  • [24] Patterns of Postoperative Transprosthesis Aortic Valve Gradients Predict Bioprosthetic Structural Valve Deterioration
    Attia, Tamer
    Soltesz, Edward
    Rajeswaran, Jeevanantham
    Roselli, Eric
    Smedira, Nicholas G.
    Sabik, Joseph F., III
    Svensson, Lars
    Blackstone, Eugene H.
    Johnston, Douglas R.
    CIRCULATION, 2015, 132
  • [25] Long-term outcomes of melody valve-in-valve implantation for bioprosthetic mitral valve dysfunction
    Joseph, Timothy A.
    Eleid, Mackram F.
    Cabalka, Allison K.
    Maalouf, Joseph F.
    Rihal, Charanjit S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (06) : 1087 - 1094
  • [26] Impact of prosthesis-patient mismatch on late outcomes after bioprosthetic mitral valve replacement for mitral regurgitation
    Kitada, Yuichiro
    Arakawa, Mamoru
    Okamura, Homare
    Akiyoshi, Kei
    Hori, Daijiro
    Kimura, Naoyuki
    Yamaguchi, Atsushi
    JOURNAL OF ARTIFICIAL ORGANS, 2022, 25 (02) : 132 - 139
  • [27] Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication
    Senage, Thomas
    Gillaizeau, Florence
    Le Tourneau, Thierry
    Marie, Basile
    Roussel, Jean-Christian
    Foucher, Yohann
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04) : 1383 - +
  • [28] Mechanical Valve Replacement Versus Bioprosthetic Valve Replacement in the Tricuspid Valve Position
    Cho, Won-Chul
    Park, Chong Bin
    Kim, Joon Bum
    Jung, Sung-Ho
    Chung, Cheol Hyun
    Choo, Suk Jung
    Lee, Jae Won
    JOURNAL OF CARDIAC SURGERY, 2013, 28 (03) : 212 - 217
  • [29] Outcomes after bioprosthetic versus mechanical mitral valve replacement for infective endocarditis in the United States
    Hogan, Katie J.
    Sylvester, Christopher B.
    Wall Jr, Matthew J.
    Rosengart, Todd K.
    Coselli, Joseph S.
    Moon, Marc R.
    Chatterjee, Subhasis
    Ghanta, Ravi K.
    JTCVS OPEN, 2024, 17
  • [30] Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses
    Wienemann, Hendrik
    Mauri, Victor
    Kuhn, Elmar
    Baldus, Stephan
    Adam, Matti
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (12) : 1396 - 1400